T80.911D Delayed hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter

Name of the Condition

• Delayed Hemolytic Transfusion Reaction, Unspecified Incompatibility, Subsequent Encounter

Summary

Delayed hemolytic transfusion reaction (DHTR) due to unspecified incompatibility is an immune-mediated adverse event occurring days to weeks after a blood transfusion, where red blood cells are destroyed prematurely. This code is used for subsequent encounters when the specific cause of incompatibility is not documented. The reaction is characterized by a delayed onset and may present with mild to moderate symptoms.

Causes

DHTR typically results from an immune response where the recipient’s antibodies attack donor red blood cells, often due to prior sensitization from previous transfusions or pregnancies. The exact incompatibility (e.g., non-ABO antigens) is not specified in this code. The reaction occurs when pre-existing antibodies react with mismatched antigens on transfused cells.

Risk Factors

• Prior transfusion or pregnancy history leading to alloantibody formation.
• Underlying conditions with increased antibody production (e.g., sickle cell disease).
• Receiving blood products from donors with incompatible antigens.
• Lack of recent crossmatching or typing.

Symptoms

• Fever or chills.
• Jaundice or yellowing of the skin.
• Dark urine (hemoglobinuria).
• Fatigue or malaise.
• Elevated bilirubin levels.
• Mild anemia or hemoglobin drop.

Diagnosis

Diagnosis involves evaluating symptoms occurring days to weeks post-transfusion, reviewing transfusion history, and conducting laboratory tests such as direct antiglobulin test (DAT), bilirubin levels, and hemoglobin/hematocrit. Documentation of the delayed onset and lack of specified incompatibility is critical.

Treatment Options

• Monitoring for symptom resolution and hemolysis.
• Supportive care, including hydration and managing anemia.
• Discontinuing the transfusion if ongoing.
• Addressing underlying causes (e.g., antibody identification).

Prognosis and Follow-Up

Most DHTR cases are mild and resolve with supportive care. Follow-up includes monitoring hemoglobin levels, bilirubin, and renal function. Severe cases may require additional interventions, but long-term complications are rare with appropriate management.

Complications

• Acute kidney injury (rare).
• Exacerbation of underlying anemia.
• Prolonged jaundice.

Lifestyle & Prevention

• Ensuring accurate blood typing and crossmatching before transfusion.
• Documenting prior transfusion or pregnancy history to guide compatibility testing.
• Using leukoreduced blood products to reduce sensitization risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as severe jaundice, dark urine, or significant fatigue occur after a transfusion, as these may indicate hemolysis requiring evaluation.

Tips for Medical Coders

Use this code for subsequent encounters when a delayed hemolytic transfusion reaction is documented without specified incompatibility. Ensure the encounter is classified as "subsequent" and that the reaction is linked to a prior transfusion. Document the absence of specified incompatibility to justify the code.